Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma
Clinical trial NCT00066196 · COMPLETED
Trial details
- NCT number
- NCT00066196
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
- Primary completion
- 2007-04-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.